Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trial

PURPOSE: The goal of chemotherapy for metastatic breast cancer (MBC) is to prolong survival and maintain health-related quality of life. This study aimed to evaluate long-term health status of patients with MBC who participated in the phase III randomized SELECT BC trial. METHODS: In the SELECT BC t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiroiwa, T., Fukuda, T., Shimozuma, K., Mouri, M., Hagiwara, Y., Doihara, H., Akabane, H., Kashiwaba, M., Watanabe, T., Ohashi, Y., Mukai, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288429/
https://www.ncbi.nlm.nih.gov/pubmed/27517267
http://dx.doi.org/10.1007/s11136-016-1388-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288429/
https://www.ncbi.nlm.nih.gov/pubmed/27517267
http://dx.doi.org/10.1007/s11136-016-1388-1

Ejemplares similares